The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IMS 2024 | Navigating reimbursement for patients receiving novel therapies in Argentina
Natalia Schütz, MD, Italian Hospital of Buenos Aires, Buenos Aires, Argentina, discusses the complexities of Argentina’s healthcare system, highlighting the challenges of reimbursement for innovative drugs in both public and private sectors. Dr Schütz emphasizes the importance of patient selection to ensure that those who will benefit most from novel treatments receive them and mentions ongoing efforts to advocate for broader access to innovative therapies. This interview took place at the 21st International Myeloma Society (IMS) Annual Meeting, held in Rio de Janeiro, Brazil.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
